Umoja Biopharma’s $100 Million Series C Financing Round

Fenwick & West represented Umoja Biopharma in the transaction. Umoja Biopharma, Inc., a developer of in vivo cell therapies that aim to realize the full reach…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here